We are live on
!
Find out more
iBio
IBIO
IBIO
20 hedge funds and large institutions have $1.99M invested in iBio in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
122% more funds holding
Funds holding: 9 → 20 (+11)
113% more capital invested
Capital invested by funds: $937K → $1.99M (+$1.06M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
20
Holders Change
+11
Holders Change %
+122.22%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$502K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$400K |
| 3 |
S
SignatureFD
Atlanta,
Georgia
|
+$166K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$107K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$90.8K |
Top Sellers
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$53.4K |
| 2 |
GHA
GW Henssler & Associates
Kennesaw,
Georgia
|
-$11K |
| 3 |
Millennium Management
New York
|
-$9K |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.34K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$3K |
